A Chromeleon Ready Check is not an approved analytical start

Define what Ready Check actually tested

Thermo Fisher Scientific's official Chromeleon 7.4 guide says the chromatography data system controls instruments and supports data evaluation, processing, reporting, and backup. Its sequence instructions say that, when the queue is empty, the application performs a Ready Check and starts the queue if no errors are found. That establishes documented software behavior within the guide. It does not establish the laboratory meaning of ready for every instrument, method, sample, study, or regulated use.

Create a readiness record that names each automated check, configured condition, limit, component, data source, execution time, result, warning, override path, and software version. Separate controller service availability, instrument connection, module state, detector baseline, consumables, calibration, qualification, environmental conditions, maintenance state, and laboratory authorization. A pass can support only the conditions the configured check actually observed; untested or unavailable evidence remains unknown.

Freeze the sequence and method package

The guide describes an injection list as the primary sequence element and identifies assigned instrument, instrument methods, processing methods, report templates, and results among sequence data. Before acquisition, preserve the sequence identifier and version, injection order, sample and container identities, types, positions, expected volume, dilution or preparation references, assigned instrument, instrument-method version, processing-method version, report-template version, spectral library where applicable, and creation source such as a LIMS worklist or eWorkflow.

Link those objects to the approved analytical procedure, specification or protocol, current method authorization, instrument qualification and calibration, analyst training and role, standards and controls, reagent or column identity, and study or batch context required by the laboratory. A saved method is a stored set of commands or processing parameters; its presence does not show that the method is approved, suitable, correctly selected, validated for the intended use, or unchanged after review.

Keep system start separate from human authorization

Use distinct states for drafted, assembled, reviewed, authorized, queued, ready-check passed, started, acquiring, interrupted, completed, processed, technically reviewed, approved, reported, and archived. Record who or what moved the sequence into each state and under which role or policy. If an authorized start is automated, retain the approved rule, qualifying conditions, owner, version, exception path, and evidence that those conditions were met for the exact sequence.

Warnings, overrides, substitutions, late sample changes, method edits, instrument changes, failed injections, reinjections, aborted runs, manual integrations, and reprocessing require their own reason and review trail. A queue that starts without a software error cannot prove sample identity, system suitability, scientific validity, data integrity, conformity with a procedure, acceptable results, batch disposition, or regulatory compliance. Those conclusions belong to the laboratory's defined review and decision process.

Demonstrate the start boundary with exceptions

A representative test should build a sequence from known samples, controls, an approved instrument method, a processing method, and a report template. Inspect the exact Ready Check result and audit evidence. Then introduce an unavailable module, unstable baseline, expired calibration, wrong instrument assignment, changed method, missing control, duplicated sample, stale worklist, insufficient role, and an instrument that reconnects after interruption. Record which condition is detected automatically and which requires procedural or scientific review.

Confirm that failed or overridden conditions cannot disappear when the sequence is restarted or copied, and that later processing and reporting remain tied to the acquired raw data and exact method versions. Lab Systems Index reviewed the registered Chromeleon 7.4 Quick Start Guide on September 12, 2026. It did not operate Chromeleon, inspect a configuration, run an instrument, review a method or sample, assess validation, or observe a scientific result. The documentation supports the narrow software workflow described here, not analytical release or laboratory compliance.

Enterprise buyer test

Translate this change into the exact population, record type, workflow stage, decision owner, effective date, and evidence that could be affected. Ask current or prospective providers to demonstrate the named workflow with representative data and an exception—not a polished feature tour. Record what official documentation establishes, what a provider states, what the team observes, and what remains unresolved.

A defensible review also identifies the dependency outside the product. Authority interpretation, policy configuration, data quality, integrations, human judgment, approval rights, release governance, training, and retained evidence may remain customer or service responsibilities. The evaluation should preserve those boundaries instead of treating a technology claim as the complete operating model.

What we will watch next

Lab Systems Index will watch the named source and affected market records for later evidence that changes status, scope, availability, implementation timing, workflow consequence, or the limits of the initial report. A later announcement does not silently overwrite this dated account; the change ledger preserves the sequence.